Mosapride 5 mg + Methylpolysiloxane 125 mg Tablet – Manufacturer, Supplier & PCD Franchise
Mosapride 5 mg + Methylpolysiloxane 125 mg Tablet
Mosapride 5 mg + Methylpolysiloxane 125 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Fixed-Dose Combination — Gastroprokinetic agent + Antiflatulent (antifoaming agent)
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Mosapride 5 mg + Methylpolysiloxane 125 mg Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Functional dyspepsia with bloating, fullness and early satiety
- Gastro-oesophageal reflux symptoms, as adjunct
- Bloating and flatulence
- Gas-related abdominal discomfort with dyspepsia
Mechanism of Action
Mosapride — Mosapride selectively stimulates 5-HT4 receptors on enteric nerves, increasing acetylcholine release in the upper gut. This enhances gastric emptying and upper gastrointestinal motility, with little dopamine-blocking activity.
Methylpolysiloxane — A silicone polymer that lowers the surface tension of gas bubbles in the gut, causing them to merge so trapped gas is passed more easily; it is not absorbed.
Combining these ingredients in one tablet provides complementary action on the target condition and simplifies therapy compared with taking the components separately.
Dosage & Administration
- Dosage of Mosapride 5 mg + Methylpolysiloxane 125 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Diarrhoea or loose stools
- Abdominal pain
- Dry mouth
- Generally well tolerated
- Mild constipation
- Nausea (rare)
Contraindications
- Known hypersensitivity to any component of the formulation
- Gastrointestinal obstruction, perforation or bleeding
- Liver impairment; monitor liver function with prolonged use
- Persistent abdominal pain needs medical evaluation
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the gastro products range product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the gastro PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.
See the full gastro range – manufacturer, supplier and PCD franchise: pantoprazole, rabeprazole, esomeprazole, vonoprazan, domperidone, ondansetron, sucralfate, antacids, laxatives and liver medicines.
PCD Pharma Franchise & Third Party Manufacturing — Mosapride + Methylpolysiloxane Tablet
- ✓ Made at WHO-GMP certified partner units — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Mosapride 5 mg + Methylpolysiloxane 125 mg. It is a fixed-dose combination of gastroprokinetic agent and antiflatulent (antifoaming agent), used for functional dyspepsia with bloating, fullness and early satiety and bloating and flatulence. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
Mosapride + Methylpolysiloxane Tablet brings together Mosapride (gastroprokinetic agent) and Methylpolysiloxane (antiflatulent) in a single fixed-dose formulation.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Mosapride + Methylpolysiloxane Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Mosapride + Methylpolysiloxane Tablet in India?
Trumac Healthcare is a supplier of Mosapride + Methylpolysiloxane Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Mosapride + Methylpolysiloxane Tablet used for?
Mosapride + Methylpolysiloxane Tablet is used for functional dyspepsia with bloating, fullness and early satiety; gastro-oesophageal reflux symptoms, as adjunct; bloating and flatulence; gas-related abdominal discomfort with dyspepsia. It should be used as advised by a registered medical practitioner.
Is Mosapride + Methylpolysiloxane Tablet available for PCD pharma franchise on monopoly basis?
Yes. Mosapride 5 mg + Methylpolysiloxane 125 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Mosapride + Methylpolysiloxane for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Mosapride + Methylpolysiloxane Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Mosapride + Methylpolysiloxane Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Mosapride + Methylpolysiloxane?
Mosapride + Methylpolysiloxane is a fixed-dose combination of gastroprokinetic agent and antiflatulent (antifoaming agent) (therapeutic class: Fixed-Dose Combination — Gastroprokinetic agent + Antiflatulent (antifoaming agent)).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Mosapride + Methylpolysiloxane Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Mosapride 5 mg + Methylpolysiloxane 125 mg Tablet?
